Discovery of protein phosphatase 2C inhibitors by virtual screening.

@article{Rogers2006DiscoveryOP,
  title={Discovery of protein phosphatase 2C inhibitors by virtual screening.},
  author={Jessica P Rogers and Albert E Beuscher and Marc Flajolet and Thomas McAvoy and Angus C. Nairn and Arthur J. Olson and Paul Greengard},
  journal={Journal of medicinal chemistry},
  year={2006},
  volume={49 5},
  pages={1658-67}
}
Protein phosphatase 2C (PP2C) is an archetype of the PPM Ser/Thr phosphatases, characterized by dependence on divalent magnesium or manganese cofactors, absence of known regulatory proteins, and resistance to all known Ser/Thr phosphatase inhibitors. We have used virtual ligand screening with the AutoDock method and the National Cancer Institute Diversity Set to identify small-molecule inhibitors of PP2Calpha activity at a protein substrate. These inhibitors are active in the micromolar range… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Virtual Screening with AutoDock: Theory and Practice.

Expert opinion on drug discovery • 2010
View 1 Excerpt

Similar Papers

Loading similar papers…